Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 930 Neoplasms 708 Prostatic Neoplasms 490 Lung Neoplasms 398 Carcinoma, Non-Small-Cell Lung 359 Colorectal Neoplasms 357 Leukemia, Myeloid, Acute 290 Pancreatic Neoplasms 238 Brain Neoplasms 227 Neoplasm Metastasis 221 Multiple Myeloma 214 Carcinoma, Hepatocellular 199 Head and Neck Neoplasms 182 Glioblastoma 181 Precursor Cell Lymphoblastic Leukemia-Lymphoma 177 Melanoma 173 Ovarian Neoplasms 168 Squamous Cell Carcinoma of Head and Neck 160 Uterine Cervical Neoplasms 144 Rectal Neoplasms 144 Recurrence 142 Hematologic Neoplasms 134 Sarcoma 133 Triple Negative Breast Neoplasms 127 Stomach Neoplasms 127 Glioma 126 Carcinoma, Renal Cell 123 Colonic Neoplasms 113 Myelodysplastic Syndromes 112 Urinary Bladder Neoplasms 109

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Cystic Neoplasm × 90 days × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡